
-
British Airways owner unveils big Boeing, Airbus order
-
IPL suspended for one week over India-Pakistan conflict
-
Slot says all at Liverpool sad to see Alexander-Arnold go
-
Leo XIV celebrates first mass as pope in Sistine Chapel
-
India says repulsed fresh Pakistan attacks as death toll climbs
-
Japan's Panasonic targets 10,000 job cuts worldwide
-
Putin evokes WWII victory to rally Russia behind Ukraine offensive
-
China exports beat forecasts ahead of US tariff talks
-
Leo XIV, the 'Latin Yankee', to celebrate first mass as pope
-
Most stocks lifted by hopes for US-China talks after UK deal
-
IPL suspended indefinitely over India-Pakistan conflict: reports
-
German lender Commerzbank's profits jump as it fends off UniCredit
-
Rare bone-eroding disease ruining lives in Kenya's poorest county
-
India says repulsed fresh Pakistan attacks as de-escalation efforts grow
-
Zhao's historic snooker title sparks talk of China world domination
-
'High expectations': EU looks to Merz for boost in tough times
-
Poisoned guests rarely invited before deadly mushroom lunch, Australia trial hears
-
China sales to US slump even as exports beat forecasts
-
Indian cricket to make 'final decision' on IPL over Pakistan conflict
-
Dethroned Bundesliga champions Leverkusen face uncertain future
-
China can play hardball at looming trade talks with US: analysts
-
French monuments in trouble while PSG prepare for Champions League final
-
Newcastle face Chelsea in top five showdown, Alexander-Arnold in spotlight
-
Flick's Barca must show 'hunger' in crunch Liga Clasico
-
Clasico the last chance saloon for Ancelotti's Real Madrid
-
Timberwolves overpower Warriors to level series
-
Chinese fabric exporters anxious for US trade patch-up
-
Putin gears up to host world leaders at lavish army parade
-
Nearing 100, Malaysian ex-PM Mahathir blasts 'old world' Trump
-
Leo XIV, first US pope, to celebrate first mass as pontiff
-
Asian stocks lifted by hopes for US-China talks after UK deal
-
Former head of crypto platform Celsius sentenced 12 years
-
Ex-model testifies in NY court that Weinstein assaulted her at 16
-
Amphastar Pharmaceuticals to Present at the 2025 Bank of America Health Care Conference
-
Ascendant Resources Announces Closing of Second and Final Tranche of Non-Brokered Private Placement
-
Nestlé and OMP Showcase Approach to Future-Ready Supply Chain at Gartner Supply Chain Symposium/Xpo in Barcelona
-
Genflow Biosciences PLC Announces Share Subscription, Director's Dealing and Update
-
Argo Blockchain PLC Announces 2024 Annual Results and Restoration of Listing
-
'Great honor': world leaders welcome first US pope
-
Pacquiao to un-retire and fight Barrios for welterweight title: report
-
Trump unveils UK trade deal, first since tariff blitz
-
Man Utd one step away from Europa League glory despite horror season
-
Jeeno shines on greens to grab LPGA lead at Liberty National
-
Mitchell fires PGA career-low 61 to grab Truist lead
-
AI tool uses selfies to predict biological age and cancer survival
-
Extremely online new pope unafraid to talk politics
-
Postecoglou hits back as Spurs reach Europa League final
-
Chelsea ease into Conference League final against Betis
-
Pope Leo XIV: Soft-spoken American spent decades amid poor in Peru
-
First US pope shared articles critical of Trump, Vance

DataMetrex Management Announces Strategic Plan
TORONTO, ON / ACCESS Newswire / February 27, 2025 / Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV:DM)(FSE:D4G)(OTC PINK:DTMXF) is pleased to provide an update on its strategic direction with its commitment to focusing on healthcare and AI businesses.
As part of its growth initiatives, Datametrex plans to bolster its healthcare sector by expanding its clinic operations to meet a broader range of healthcare needs, including family medicine, walk-in examinations, and care by a specialist. The expansion will take place primarily via Mergers and Acquisitions (M&A), which the Company has identified numerous targets to roll up, and consolidate operations to lower the overhead costs and boost profits. The Company's clinic services will also be strengthened with wellness offerings, including IV therapy, Botox, and laser treatments. In alignment with this expansion, the Company plans to acquire additional clinics and their associated properties.
The Company has decided to wind down its non-core business, such as pharmacy and mobile gaming, to focus solely on healthcare and AI, as part of its deep and narrow strategy.
As part of this strategy, the Company will initiate industry consolidation through the acquisition and integration of multiple clinics and properties. This approach aims to strengthen the Company's portfolio by expanding its network of healthcare facilities.
Datametrex will continue to focus on its AI business. It is pleased to announce that the cash flows from AI service operations have remained strong through the Company's active and strategic management and customer acquisition. The Company is committed to further expanding its market presence, optimizing its AI solutions, and exploring new partnerships to drive sustainable growth in this sector.
Looking ahead, Datametrex intends to pursue a corporate restructuring plan that will split the Company into two entities, allowing for a distinct focus on healthcare and AI business operations. This initiative is expected to enhance operational efficiency and create greater value for shareholders.
Paul Haber, CEO of Datametrex, commented, "Our company is dedicated to strengthening our focus on the healthcare and AI business and ensuring that our upcoming corporate restructuring enhances efficiency and aligns with the best interests of our shareholders. We appreciate your continued support and look forward to the next phase of our growth."
About Datametrex
Datametrex is an innovative leader in Technology Solutions, Artificial Intelligence, Healthcare, and Mobile Gaming. The Company excels in delivering tools and solutions that enhance operational efficiencies and business outcomes. With a commitment to innovation, Datametrex is dedicated to supporting enterprises by setting a new standard for business protocols through cutting-edge technology.
For more on Datametrex, please visit our Company website.
For Additional Information
Paul Haber, C.P.A., C.A., C.Dir
CEO & Chairman
[email protected]
(416) 318-6501
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains "forward-looking statements," which involve risks, uncertainties, and factors that could cause actual results to differ materially from those anticipated. These statements are not historical facts and are generally identified by words such as "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," and similar expressions. Such statements include expectations related to healthcare business and other Company plans.
While Datametrex believes the forward-looking information is reasonable as of the date of this release, these statements involve assumptions, risks, and uncertainties that could cause actual outcomes to differ. Key factors include general economic conditions, legislative and regulatory developments, access to capital, industry competition, and the Company's ability to execute its strategies. The Company does not undertake to update these statements, except as required by law. Readers are advised not to place undue reliance on forward-looking information.
Factors that could cause actual results to differ materially are detailed under "Risk Factors" in Datametrex's management's discussion and analysis and available on the Company's profile at www.sedarplus.ca.
This release does not constitute an offer to sell or a solicitation to buy, nor shall it constitute an offer, solicitation, or sale in any jurisdiction where such would be unlawful prior to registration or qualification under applicable securities laws. We seek Safe Harbor.
SOURCE: DataMetrex AI Ltd.
View the original press release on ACCESS Newswire
Ch.Kahalev--AMWN